Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00420017 · ClinicalTrials.gov registry record · Phase 4

Prevention of Atrial Fibrillation Following Esophagectomy

A Phase 4 study of Atrial Fibrillation and Esophagectomy, sponsored by Indiana University.

Completed
Registry status
Phase 4
Development phase
80
Enrollment target
1
Study location

NCT00420017: Completed Phase 4 study of Atrial Fibrillation and Esophagectomy, sponsored by Indiana University.

NCT00420017 is a Phase 4 study of Atrial Fibrillation and Esophagectomy that has completed, run by Indiana University. The registered enrollment target is 80 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00420017, a Phase 4 study of Atrial Fibrillation and Esophagectomy, has completed, sponsored by Indiana University.

COMPLETED
Registry status
Phase 4
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The investigators hypothesize that the medication amiodarone decreases the incidence of atrial fibrillation (AF) following esophagectomy surgery. Their specific aims are to: Determine the effectiveness of amiodarone for the prevention of AF following esophagectomy surgery; Determine the influence of the prevention of AF following esophagectomy surgery on post-surgical duration of stay in the Intensive Care Unit ICU)and duration of post-surgical hospital stay; and Determine the safety of amiodarone for the prevention of AF following esophagectomy surgery.

Conditions Studied

Atrial Fibrillation Esophagectomy

Interventions

  • OTHER Control
  • DRUG Amiodarone

Study Locations (1)

Indiana

  • Indiana University Hospital - Indianapolis

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2005-09
Est. Completion 2008-11
Phase Phase 4
Indiana University

890 total trials

What the finished NCT00420017 record still lists

NCT00420017 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT00420017 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT00420017 about?

NCT00420017 is a clinical study titled "Prevention of Atrial Fibrillation Following Esophagectomy". The investigators hypothesize that the medication amiodarone decreases the incidence of atrial fibrillation (AF) following esophagectomy surgery. Their specific aims are to: Determine the effectiveness of amiodarone for the prevention of AF following esophagectomy surgery; Determine the influence o...

What is the current status of trial NCT00420017?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2005-09. Estimated completion is 2008-11.

What conditions does trial NCT00420017 study?

This clinical trial studies the following conditions: Atrial Fibrillation, Esophagectomy.

What interventions are being tested in trial NCT00420017?

The interventions under investigation include: Control (OTHER), Amiodarone (DRUG).

Who is sponsoring clinical trial NCT00420017?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00420017 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00420017's enrollment target sits among peer trials

80 153rd of 202 higher than 49 of 202 other Atrial Fibrillation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00420017, the US trial registry maintained by the National Library of Medicine. NCT00420017 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.